Trade Novavax NVAX

Novavax live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2025 Mar 31, 21:34

Health Care Up on Defensive Rotation - Health Care Roundup | Morningstar

Novavax Inc
Trading Central 2025 Mar 31, 21:11

US Market Brief: S&P 500 and Dow Jones Kick Off Week in Positive Fashion

Novavax Inc
Webhose 2025 Mar 31, 17:20

Novavax (NASDAQ:NVAX) Shares Gap Down - Here's Why

Novavax Inc
Webhose 2025 Mar 30, 21:51

Novavax, Inc. (NVAX): Among Top High-Risk, High-Reward Growth Stocks To Buy Now

Novavax Inc
Webhose 2025 Mar 28, 07:31

Swiss National Bank Boosts Stake in Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Mar 24, 06:54

Zacks Research Comments on Novavax FY2027 Earnings

Novavax Inc
Webhose 2025 Mar 19, 18:04

Novavax (NASDAQ:NVAX) Stock Price Down 6.1% - Here's Why

Novavax Inc
Webhose 2025 Mar 16, 08:44

Novavax, Inc. (NASDAQ:NVAX) Receives $18.00 Average Price Target from Brokerages

Novavax Inc
Webhose 2025 Mar 13, 15:25

Novavax call volume above normal and directionally bullish | Markets Insider

Novavax Inc
Webhose 2025 Mar 11, 12:35

Novavax announces Young to retire as Chair of the Board, McGlynn to succeed | Markets Insider

Novavax Inc
Webhose 2025 Mar 11, 12:05

Novavax Names Margaret McGlynn Board Chair, Replacing Young

Novavax Inc
Webhose 2025 Mar 11, 08:16

Novavax Appoints Margaret McGlynn To Succeed James Young As Chair Of The Board

Novavax Inc
Webhose 2025 Mar 08, 17:52

Novavax (NASDAQ:NVAX) Stock Price Up 6.7% - Here's Why

Novavax Inc
Webhose 2025 Mar 06, 09:19

SBI Securities Co. Ltd. Buys Shares of 34,485 Novavax, Inc. (NASDAQ:NVAX)

Novavax Inc
Webhose 2025 Mar 03, 06:49

What is Zacks Research's Forecast for Novavax Q1 Earnings?

Novavax Inc

Latest news

Info

Spread

0.05

Spread (%)

0.8319 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Market open

Tuesday

13:31 - 19:59

Monday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

1125910016

Shares Outstanding

160844000

Earnings Date (Next)

2019-05-10

Div Yield

2019-05-10

Ex-Dividend Date 

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-1.23

Learn more about this instrument

Novavax Novavax Inc
Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Related Instruments

Asset
Sell
Buy
Change (%)
view_all_instruments
Trustpilot